US Stock MarketDetailed Quotes

Viking Therapeutics (VKTX)

Watchlist
  • 30.000
  • -1.180-3.78%
Close May 1 15:59 ET
  • 29.990
  • -0.010-0.03%
Post 19:22 ET
3.48BMarket Cap-7.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics (VKTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-117.80%-113.98M
-217.45%-278.69M
-173.53%-85.29M
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
Net income from continuing operations
-246.98%-158.33M
-227.05%-359.64M
-345.16%-157.66M
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
Operating gains losses
----
50.89%-55K
-4,000.00%-41K
91.15%-10K
----
----
---112K
---1K
---113K
----
Depreciation and amortization
-23.42%85K
24.57%431K
-14.55%94K
31.03%114K
49.33%112K
50.00%111K
18.49%346K
48.65%110K
19.18%87K
2.74%75K
Other non cash items
-97.06%1K
-50.00%66K
-145.71%-16K
-51.52%16K
18.52%32K
-8.11%34K
0.76%132K
-2.78%35K
175.00%33K
-37.21%27K
Change In working capital
333.83%35.22M
423.16%48.98M
2,566.08%65.48M
-737.50%-8.64M
189.90%7.2M
-194.43%-15.06M
163.87%9.36M
-55.16%2.46M
-170.93%-1.03M
-259.62%-8.01M
-Change in receivables
-62.11%936K
323.35%5.08M
163.93%413K
63.62%2.2M
92.99%-11K
277.10%2.47M
273.52%1.2M
-539.60%-646K
447.56%1.35M
-134.33%-157K
-Change in prepaid assets
148.44%4.63M
-1,265.70%-5.2M
848.70%14.28M
-77.20%-4.83M
-6,341.77%-5.09M
-646.57%-9.55M
-93.04%446K
2,694.83%1.51M
-298.69%-2.73M
-101.07%-79K
-Change in payables and accrued expense
479.59%29.79M
510.99%49.61M
2,850.96%50.9M
-1,422.02%-5.88M
261.75%12.43M
-157.56%-7.85M
386.49%8.12M
-69.86%1.73M
677.92%445K
-253.26%-7.69M
-Change in other current liabilities
-7.75%-139K
-25.62%-505K
9.38%-116K
-35.42%-130K
-44.44%-130K
-46.59%-129K
-15.85%-402K
-47.13%-128K
-10.34%-96K
-2.27%-90K
Cash from discontinued investing activities
Operating cash flow
-117.80%-113.98M
-217.45%-278.69M
-173.53%-85.29M
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
Investing cash flow
Cash flow from continuing investing activities
-14.32%54.19M
161.69%341.39M
1,048.42%75.61M
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
Net investment purchase and sale
-14.32%54.19M
161.69%341.39M
1,048.42%75.61M
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
Cash from discontinued investing activities
Investing cash flow
-14.32%54.19M
161.69%341.39M
1,048.42%75.61M
517.83%160.03M
133.72%42.51M
113.76%63.25M
-208.99%-553.37M
-81.57%6.58M
306.65%25.9M
38.35%-126.06M
Financing cash flow
Cash flow from continuing financing activities
3,360.46%12.08M
-87.52%76.44M
7,410.30%75.1M
-80.97%480K
-82.55%507K
-99.94%349K
125.69%612.46M
431.91%1M
3,508.11%2.52M
-98.91%2.91M
Net common stock issuance
--11.63M
--0
--0
--0
--0
--0
121.34%597.09M
-2,269.63%-46.66M
2,360.86%46.66M
-100.01%-25K
Proceeds from stock option exercised by employees
28.94%450K
-76.96%2.49M
15.50%1.16M
-80.97%480K
-82.70%507K
-92.00%349K
59.77%10.81M
431.91%1M
252,300.00%2.52M
12.05%2.93M
Net other financing activities
----
1,522.73%73.95M
----
----
----
----
188.45%4.56M
2,269.63%46.66M
-2,269.63%-46.66M
--0
Cash from discontinued financing activities
Financing cash flow
3,360.46%12.08M
-87.52%76.44M
7,410.30%75.1M
-80.97%480K
-82.55%507K
-99.94%349K
125.69%612.46M
431.91%1M
3,508.11%2.52M
-98.91%2.91M
Net cash flow
Beginning cash position
521.57%165.81M
-51.95%26.68M
99.37%100.38M
-22.85%33.88M
-80.60%37.94M
-51.95%26.68M
51.55%55.52M
35.40%50.35M
-36.83%43.92M
965.13%195.58M
Current changes in cash
-523.60%-47.71M
584.95%139.14M
377.26%65.43M
929.28%66.5M
97.33%-4.05M
-91.96%11.26M
-251.70%-28.69M
-229.08%-23.6M
120.02%6.46M
-396.46%-151.67M
Effect of exchange rate changes
1,500.00%16K
94.59%-8K
112.16%9K
79.31%-6K
-500.00%-12K
102.08%1K
-393.33%-148K
-248.00%-74K
57.35%-29K
200.00%3K
End cash Position
211.32%118.12M
521.57%165.81M
521.57%165.81M
99.37%100.38M
-22.85%33.88M
-80.60%37.94M
-51.95%26.68M
-51.95%26.68M
35.40%50.35M
-36.83%43.92M
Free cash flow
-117.80%-113.98M
-217.45%-278.69M
-173.53%-85.29M
-328.03%-94M
-65.05%-47.06M
-753.13%-52.33M
-19.64%-87.79M
-76.76%-31.18M
-11.72%-21.96M
-149.35%-28.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -117.80%-113.98M-217.45%-278.69M-173.53%-85.29M-328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M
Net income from continuing operations -246.98%-158.33M-227.05%-359.64M-345.16%-157.66M-264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M
Operating gains losses ----50.89%-55K-4,000.00%-41K91.15%-10K-----------112K---1K---113K----
Depreciation and amortization -23.42%85K24.57%431K-14.55%94K31.03%114K49.33%112K50.00%111K18.49%346K48.65%110K19.18%87K2.74%75K
Other non cash items -97.06%1K-50.00%66K-145.71%-16K-51.52%16K18.52%32K-8.11%34K0.76%132K-2.78%35K175.00%33K-37.21%27K
Change In working capital 333.83%35.22M423.16%48.98M2,566.08%65.48M-737.50%-8.64M189.90%7.2M-194.43%-15.06M163.87%9.36M-55.16%2.46M-170.93%-1.03M-259.62%-8.01M
-Change in receivables -62.11%936K323.35%5.08M163.93%413K63.62%2.2M92.99%-11K277.10%2.47M273.52%1.2M-539.60%-646K447.56%1.35M-134.33%-157K
-Change in prepaid assets 148.44%4.63M-1,265.70%-5.2M848.70%14.28M-77.20%-4.83M-6,341.77%-5.09M-646.57%-9.55M-93.04%446K2,694.83%1.51M-298.69%-2.73M-101.07%-79K
-Change in payables and accrued expense 479.59%29.79M510.99%49.61M2,850.96%50.9M-1,422.02%-5.88M261.75%12.43M-157.56%-7.85M386.49%8.12M-69.86%1.73M677.92%445K-253.26%-7.69M
-Change in other current liabilities -7.75%-139K-25.62%-505K9.38%-116K-35.42%-130K-44.44%-130K-46.59%-129K-15.85%-402K-47.13%-128K-10.34%-96K-2.27%-90K
Cash from discontinued investing activities
Operating cash flow -117.80%-113.98M-217.45%-278.69M-173.53%-85.29M-328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M
Investing cash flow
Cash flow from continuing investing activities -14.32%54.19M161.69%341.39M1,048.42%75.61M517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M
Net investment purchase and sale -14.32%54.19M161.69%341.39M1,048.42%75.61M517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M
Cash from discontinued investing activities
Investing cash flow -14.32%54.19M161.69%341.39M1,048.42%75.61M517.83%160.03M133.72%42.51M113.76%63.25M-208.99%-553.37M-81.57%6.58M306.65%25.9M38.35%-126.06M
Financing cash flow
Cash flow from continuing financing activities 3,360.46%12.08M-87.52%76.44M7,410.30%75.1M-80.97%480K-82.55%507K-99.94%349K125.69%612.46M431.91%1M3,508.11%2.52M-98.91%2.91M
Net common stock issuance --11.63M--0--0--0--0--0121.34%597.09M-2,269.63%-46.66M2,360.86%46.66M-100.01%-25K
Proceeds from stock option exercised by employees 28.94%450K-76.96%2.49M15.50%1.16M-80.97%480K-82.70%507K-92.00%349K59.77%10.81M431.91%1M252,300.00%2.52M12.05%2.93M
Net other financing activities ----1,522.73%73.95M----------------188.45%4.56M2,269.63%46.66M-2,269.63%-46.66M--0
Cash from discontinued financing activities
Financing cash flow 3,360.46%12.08M-87.52%76.44M7,410.30%75.1M-80.97%480K-82.55%507K-99.94%349K125.69%612.46M431.91%1M3,508.11%2.52M-98.91%2.91M
Net cash flow
Beginning cash position 521.57%165.81M-51.95%26.68M99.37%100.38M-22.85%33.88M-80.60%37.94M-51.95%26.68M51.55%55.52M35.40%50.35M-36.83%43.92M965.13%195.58M
Current changes in cash -523.60%-47.71M584.95%139.14M377.26%65.43M929.28%66.5M97.33%-4.05M-91.96%11.26M-251.70%-28.69M-229.08%-23.6M120.02%6.46M-396.46%-151.67M
Effect of exchange rate changes 1,500.00%16K94.59%-8K112.16%9K79.31%-6K-500.00%-12K102.08%1K-393.33%-148K-248.00%-74K57.35%-29K200.00%3K
End cash Position 211.32%118.12M521.57%165.81M521.57%165.81M99.37%100.38M-22.85%33.88M-80.60%37.94M-51.95%26.68M-51.95%26.68M35.40%50.35M-36.83%43.92M
Free cash flow -117.80%-113.98M-217.45%-278.69M-173.53%-85.29M-328.03%-94M-65.05%-47.06M-753.13%-52.33M-19.64%-87.79M-76.76%-31.18M-11.72%-21.96M-149.35%-28.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -